ReviewClinical ophthalmology (Auckland, N.Z.)2022

Practical Guidance for the Use of Loteprednol Etabonate Ophthalmic Suspension 0.25% in the Management of Dry Eye Disease.

Nandini Venkateswaran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.